PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Nov-2023 Radial Compression Devices Industry is expected to undergo substantial growth, as indicated by FMI’s projection of US$ 599.9 Million by 2033 at a CAGR of 8.9% | FMI Says MARKITWIRED
07-Nov-2023 Evotec and Dewpoint Therapeutics enter strategic partnership in oncology Evotec SE
07-Nov-2023 Aura Biosciences Announces Pricing of Public Offering of Common Stock Businesswire
07-Nov-2023 Il Comitato per il ripristino del valore per gli azionisti Nymox offre agli azionisti Nymox un aggiornamento fattuale sulla Riunione speciale Businesswire
07-Nov-2023 Het Committee to Restore Nymox Shareholder Value biedt inhoudelijke update aan de Nymox-aandeelhouders met betrekking tot de Speciale Vergadering Businesswire
07-Nov-2023 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
07-Nov-2023 Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-Line Treatment for Upper GI Cancers Businesswire
07-Nov-2023 Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-line Treatment for Upper GI Cancers Businesswire
07-Nov-2023 Redwire Corporation Reports Third Quarter 2023 Financial Results Businesswire
07-Nov-2023 MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock Businesswire
07-Nov-2023 Exploring Bovine Mastitis Market 2023 : Projected to Witness Substantial Expansion, CAGR of 6.3%, Claims AMR The Wire Times
07-Nov-2023 El Committee to Restore Nymox Shareholder Value proporciona información actualizada a los accionistas de Nymox sobre la Asamblea Especial Businesswire
07-Nov-2023 Das Committee to Restore Nymox Shareholder Value informiert die Nymox-Aktionäre über die außerordentlichen Versammlung Businesswire
07-Nov-2023 Fabrinet Announces First Quarter Fiscal Year 2024 Financial Results Businesswire
07-Nov-2023 Aura Biosciences Announces Proposed Public Offering of Common Stock Businesswire
07-Nov-2023 Werner Appoints Michelle D. Greene to Board of Directors Businesswire
07-Nov-2023 Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress Businesswire
06-Nov-2023 Aura Biosciences Receives FDA Agreement Under Special Protocol Assessment (SPA) for CoMpass Phase 3 Clinical Trial of Belzupacap Sarotalocan (Bel-sar) in Early-stage Choroidal Melanoma Businesswire
06-Nov-2023 Brainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc. Businesswire
06-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AdaptHealth Corp. (AHCO) on Behalf of Investors Businesswire